AveXis-BioLife Licenses Spinal Muscular Atrophy Gene Therapy Program dne October 24, 2013 AveXis Biolife spinal muscular atrophy +1 spinal muscular atrophy gene therapy spinal muscular atrophy research AveXis Biolife spinal muscular atrophy spinal muscular atrophy gene therapy spinal muscular atrophy research
Isis Pharmaceuticals Advances Phase 2 Study of ISIS-SMN Rx in Infants with SMA dne October 04, 2013 clinical trials ISIS Pharmaceuticals +2 ISIS SMNrx spinal muscular atrophy spinal muscular atrophy cure spinal muscular atrophy research clinical trials ISIS Pharmaceuticals ISIS SMNrx spinal muscular atrophy spinal muscular atrophy cure spinal muscular atrophy research